Bonk (NASDAQ:BNKK) Announces Quarterly Earnings Results

Bonk (NASDAQ:BNKK) released its quarterly earnings data on Tuesday. The company reported ($8.27) earnings per share for the quarter, FiscalAI reports. The business had revenue of $1.82 million for the quarter.

Bonk Trading Down 3.8%

Shares of Bonk stock opened at $2.51 on Thursday. Bonk has a twelve month low of $2.31 and a twelve month high of $46.90. The firm’s 50 day moving average is $3.53. The company has a market capitalization of $13.20 million, a P/E ratio of -0.33 and a beta of 2.10.

Analyst Ratings Changes

A number of equities research analysts have recently commented on BNKK shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bonk in a report on Friday, March 27th. Wall Street Zen upgraded shares of Bonk to a “sell” rating in a report on Saturday, December 13th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Bonk has an average rating of “Sell”.

Hedge Funds Weigh In On Bonk

Several hedge funds and other institutional investors have recently modified their holdings of BNKK. State Street Corp bought a new stake in shares of Bonk in the fourth quarter worth $33,000. Steward Partners Investment Advisory LLC purchased a new position in Bonk in the fourth quarter worth about $37,000. Jane Street Group LLC bought a new stake in shares of Bonk during the 4th quarter valued at about $96,000. Finally, Geode Capital Management LLC bought a new stake in shares of Bonk during the 4th quarter valued at about $128,000. 12.55% of the stock is owned by institutional investors.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.